BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37308486)

  • 1. Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid.
    Qin XY; Furutani Y; Yonezawa K; Shimizu N; Kato-Murayama M; Shirouzu M; Xu Y; Yamano Y; Wada A; Gailhouste L; Shrestha R; Takahashi M; Keillor JW; Su T; Yu W; Fujii S; Kagechika H; Dohmae N; Shirakami Y; Shimizu M; Masaki T; Matsuura T; Suzuki H; Kojima S
    Cell Death Dis; 2023 Jun; 14(6):358. PubMed ID: 37308486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism by which acyclic retinoid induces nuclear localization of transglutaminase 2 in human hepatocellular carcinoma cells.
    Shrestha R; Tatsukawa H; Shrestha R; Ishibashi N; Matsuura T; Kagechika H; Kose S; Hitomi K; Imamoto N; Kojima S
    Cell Death Dis; 2015 Dec; 6(12):e2002. PubMed ID: 26633708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.
    Qin XY; Suzuki H; Honda M; Okada H; Kaneko S; Inoue I; Ebisui E; Hashimoto K; Carninci P; Kanki K; Tatsukawa H; Ishibashi N; Masaki T; Matsuura T; Kagechika H; Toriguchi K; Hatano E; Shirakami Y; Shiota G; Shimizu M; Moriwaki H; Kojima S
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4969-4974. PubMed ID: 29686061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transglutaminase-mediated hepatic cell death in alcoholic steatohepatitis and non-alcoholic steatohepatitis.
    Kojima S; Kuo TF; Tatsukawa H
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():52-7. PubMed ID: 22320917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells.
    Tatsukawa H; Sano T; Fukaya Y; Ishibashi N; Watanabe M; Okuno M; Moriwaki H; Kojima S
    Mol Cancer; 2011 Jan; 10():4. PubMed ID: 21214951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.
    Rorke EA; Adhikary G; Szmacinski H; Lakowicz JR; Weber DJ; Godoy-Ruiz R; Puranik P; Keillor JW; Gates EWJ; Eckert RL
    Mol Carcinog; 2022 Jan; 61(1):19-32. PubMed ID: 34610184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype.
    Gates EWJ; Calvert ND; Cundy NJ; Brugnoli F; Navals P; Kirby A; Bianchi N; Adhikary G; Shuhendler AJ; Eckert RL; Keillor JW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid desaturation-associated endoplasmic reticulum stress regulates MYCN gene expression in hepatocellular carcinoma cells.
    Qin XY; Su T; Yu W; Kojima S
    Cell Death Dis; 2020 Jan; 11(1):66. PubMed ID: 31988297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways.
    Shao RX; Otsuka M; Kato N; Taniguchi H; Hoshida Y; Moriyama M; Kawabe T; Omata M
    Gastroenterology; 2005 Jan; 128(1):86-95. PubMed ID: 15633126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated Fibroblasts induce epithelial-mesenchymal transition
    Jia C; Wang G; Wang T; Fu B; Zhang Y; Huang L; Deng Y; Chen G; Wu X; Chen J; Pan Y; Tai Y; Liang J; Li X; Hu K; Xie B; Li S; Yang Y; Chen G; Zhang Q; Liu W
    Int J Biol Sci; 2020; 16(14):2542-2558. PubMed ID: 32792856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
    Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
    Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Outside-In Journey of Tissue Transglutaminase in Cancer.
    Sima LE; Matei D; Condello S
    Cells; 2022 May; 11(11):. PubMed ID: 35681474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.
    Condello S; Sima L; Ivan C; Cardenas H; Schiltz G; Mishra RK; Matei D
    Cancer Res; 2018 Jun; 78(11):2990-3001. PubMed ID: 29510995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma.
    Chen H; Nio K; Yamashita T; Okada H; Li R; Suda T; Li Y; Doan PTB; Seki A; Nakagawa H; Toyama T; Terashima T; Iida N; Shimakami T; Takatori H; Kawaguchi K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    Mol Oncol; 2021 Aug; 15(8):2203-2218. PubMed ID: 33834612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
    Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
    Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1.
    Ding LJ; Li Y; Wang SD; Wang XS; Fang F; Wang WY; Lv P; Zhao DH; Wei F; Qi L
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer.
    Wang Q; Liang N; Yang T; Li Y; Li J; Huang Q; Wu C; Sun L; Zhou X; Cheng X; Zhao L; Wang G; Chen Z; He X; Liu C
    J Hepatol; 2021 Nov; 75(5):1142-1153. PubMed ID: 34217777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.